NCT02596230 RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism Status COMPLETED Phase N/A
NCT02596217 Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers Status COMPLETED Phase PHASE1
NCT02591225 Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon Status UNKNOWN Phase PHASE4
NCT02589639 Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT02589626 Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA Status COMPLETED Phase PHASE4
NCT02580591 Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) Status COMPLETED Phase PHASE3
NCT02579603 Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF Status COMPLETED Phase PHASE4
NCT02577315 Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions Status COMPLETED Phase PHASE1
NCT02574845 DDI (Effect of Metformin and Furosemide on Rosuvastatin PK) Status COMPLETED Phase PHASE1
NCT02572752 Relative Bioavailability of 2 Oral Formulations of Nintedanib Status COMPLETED Phase PHASE1
NCT02572609 Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride Status COMPLETED Phase PHASE1
NCT02569528 ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1 Status COMPLETED Phase N/A
NCT02551068 High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib Status COMPLETED Phase NA
NCT02538614 Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE1
NCT02533960 Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime Status COMPLETED Phase N/A
NCT02531737 Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer Status COMPLETED Phase PHASE2
NCT02525679 Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02516553 BI 894999 First in Human Dose Finding Study in Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02516098 Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide. Status COMPLETED Phase PHASE1